Effects of lipids and lipoproteins on thrombosis and rheology

被引:164
作者
Rosenson, RS
Lowe, GDO
机构
[1] Rush Presbyterian St Lukes Med Ctr, Dept Med, Cardiol Sect, Chicago, IL 60612 USA
[2] Rush Presbyterian St Lukes Med Ctr, Dept Pathol, Cardiol Sect, Chicago, IL 60612 USA
[3] Univ Glasgow, Royal Infirm, Dept Med, Glasgow G31 2ER, Lanark, Scotland
关键词
rheology; thrombosis; fibrinolysis; viscosity; coronary heart disease (CHD) risk; hemostasis;
D O I
10.1016/S0021-9150(98)00144-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerotic plaque rupture and erosions precipitate thrombus formation and may lead to an acute ischemic syndrome. Lipids and lipoproteins modulate the expression and/or function of thrombotic, fibrinolytic and theologic factors, and thereby influence hemostasis and potential tissue damage resulting from vascular injury. Triglyceride-enriched lipoproteins are accompanied by elevations in factor VII clotting activity, plasminogen activator inhibitor (PAI-I) and viscosity of blood and plasma. Low density lipoprotein (LDL) promotes platelet activation and tissue factor expression and LDL levels correlate with levels of vitamin K dependent coagulation factors and fibrinogen. Conversely, LDL inhibits tissue factor pathway inhibitor (TFPI) which limits activation of the extrinsic coagulation pathway. High density lipoprotein (HDL) has anti-atherothrombotic properties that result from inhibition of platelet and erythrocyte aggregation, reduced blood viscosity and suppression of tissue factor activity and PAI-I activity and antigen levels. The effects of lipids and lipoproteins on hemostasis and rheology may have important implications for the clinical sequelae following plaque disruption and erosion. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:271 / 280
页数:10
相关论文
共 132 条
[71]  
LOWE GDO, 1991, THROMB HAEMOSTASIS, V65, P339
[72]  
LOWE GDO, 1980, THROMB HAEMOSTASIS, V42, P1503
[73]   Blood viscosity and risk of cardiovascular events: The Edinburgh Artery Study [J].
Lowe, GDO ;
Lee, AJ ;
Rumley, A ;
Price, JF ;
Fowkes, FGR .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 96 (01) :168-173
[74]  
LOWE GDO, 1995, EUR HEART J SA, V16
[75]  
LOWE GDO, 1979, THROMB DIATH HAEMO, V42, P1503
[76]   LOCALIZATION AND PRODUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN HUMAN HEALTHY AND ATHEROSCLEROTIC ARTERIES [J].
LUPU, F ;
BERGONZELLI, GE ;
HEIM, DA ;
COUSIN, E ;
GENTON, CY ;
BACHMANN, F ;
KRUITHOF, EKO .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (07) :1090-1100
[77]   Atorvastatin: An effective lipid-modifying agent in familial hypercholesterolemia [J].
Marais, AD ;
Firth, JC ;
Bateman, ME ;
Byrnes, P ;
Martens, C ;
Mountney, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (08) :1527-1531
[78]  
MARGUERIE GA, 1979, J BIOL CHEM, V254, P5357
[79]   Identification of active tissue factor in human coronary atheroma [J].
Marmur, JD ;
Thiruvikraman, SV ;
Fyfe, BS ;
Guhu, A ;
Sharma, SK ;
Ambrose, JA ;
Fallon, JT ;
Nemerson, Y ;
Taubman, MB .
CIRCULATION, 1996, 94 (06) :1226-1232
[80]   INFLUENCE OF PLATELET SIZE ON OUTCOME AFTER MYOCARDIAL-INFARCTION [J].
MARTIN, JF ;
BATH, PMW ;
BURR, ML .
LANCET, 1991, 338 (8780) :1409-1411